ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

KTTA Pasithea Therapeutics Corporation

6.92
0.00 (0.00%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Pasithea Therapeutics Corporation KTTA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 6.92 19:00:00
Open Price Low Price High Price Close Price Previous Close
7.17 7.17 7.17 6.92 6.92
more quote information »

Recent News

Date Time Source Heading
4/29/202406:59GLOBEPasithea Therapeutics Announces PAS-004 Abstract Accepted..
4/24/202406:59GLOBEPasithea Therapeutics Announces the First Cohort has..
3/01/202420:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202420:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202406:59GLOBEPasithea Therapeutics Announces Opening of Enrollment in the..
1/18/202415:30EDGAR2Form 8-K - Current report
1/08/202406:59GLOBEPasithea Therapeutics Announces Invention of Crystalline..
1/02/202415:47EDGAR2Form 8-K - Current report
1/02/202407:35GLOBEPasithea Therapeutics Announces FDA Acceptance of IND..
12/28/202316:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/28/202316:00GLOBEPasithea Therapeutics Announces Adjournment of Reconvened..
12/28/202310:30EDGAR2Form 8-K - Current report
12/19/202316:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/19/202316:21EDGAR2Form 8-K - Current report
12/19/202316:19GLOBEPasithea Therapeutics Announces Results from 2023 Annual..
12/11/202307:01GLOBEPasithea Therapeutics Announces Positive In Vivo Preclinical..
11/29/202316:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/29/202315:27GLOBEPasithea Therapeutics Announces Adjournment of 2023 Annual..
11/29/202306:59GLOBEPasithea Therapeutics Announces Outcome of Pre-IND Meeting..
11/13/202315:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:59GLOBEPasithea Therapeutics Selects PAS-003 Lead Development..
10/26/202316:01EDGAR2Form ARS - Annual Report to Security Holders
10/26/202316:00EDGAR2Form DEF 14A - Other definitive proxy statements
10/16/202316:18EDGAR2Form PRE 14A - Other preliminary proxy statements
10/13/202316:00EDGAR2Form 8-K - Current report
9/14/202308:15EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
9/14/202308:11EDGAR2Form 8-K - Current report
9/14/202307:30GLOBEPasithea Therapeutics Corp. Announces Final Results of..
9/07/202315:14GLOBEPasithea Therapeutics to Participate in H.C. Wainwright 25th..
8/24/202316:00EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
8/21/202316:22EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
8/14/202308:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
8/11/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202308:08EDGAR2Form SC TO-I - Tender offer statement by Issuer
8/01/202306:59GLOBEPasithea Therapeutics publishes study in Proceedings of the..
7/20/202308:03EDGAR2Form SC TO-C - Written communication relating to an issuer..
7/20/202307:56EDGAR2Form 8-K - Current report
7/20/202307:43GLOBEPasithea Therapeutics Announces Intention to Commence a..
7/20/202307:40GLOBEPasithea Therapeutics Special Committee Rejects Unsolicited..
7/20/202307:31EDGAR2Form 8-K - Current report
7/03/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
6/30/202308:28GLOBEPasithea Therapeutics Confirms Previous Creation of..
6/29/202313:50GLOBELucy Scientific Discovery Reiterates Its Proposal to Acquire..
6/29/202307:29GLOBEPasithea Therapeutics Announces Completion of GMP..
6/06/202315:30GLOBEPasithea Therapeutics Confirms Receipt of Unsolicited..
6/05/202308:00GLOBELucy Scientific Discovery Announces Proposal to Acquire..
6/01/202306:57GLOBEPasithea Therapeutics Abstract Accepted for Poster..

Your Recent History

Delayed Upgrade Clock